̽ѡ

Autism and perinatal epidemiology – Sven Sandin research group

We are investigating the underlying causes and factors influencing the risk of autism, preterm birth and related factors and diagnoses. Our approach is to use modern statistical and epidemiological methods to extract and synthesize information from large population-based databases, and to collect new data as needed. We work in close collaboration with universities mainly in the Nordic countries, the USA and Israel.

Part of the:

Our research

Today, there is a wealth of large databases describing the health and demographics of different populations. The availability of data alone, however, is not sufficient to understand the underlying causes and life course of common diseases and disorders. We apply modern statistical and epidemiological methods to extract and create new data and information from these data sources. To fully understand how the information can answer our various research questions, we need expertise from a spectrum of research disciplines. These include international experts in biostatistics, data science and data management, epidemiology, public health, clinical expertise, biology and genetics.

Publications

All publications from group members

  • Article: BIOGERONTOLOGY. 2025;26(1):34
    Yin W; Li X; Chen R; Zhan Y; Jylhava J; Fang F; Hagg S
  • Article: ANNALS OF EPIDEMIOLOGY. 2024;97:23-32
    Mboya IB; Fritz J; da Silva M; Sun M; Wahlstrom J; Magnusson PKE; Sandin S; Yin W; Soderberg S; Pedersen NL; Lagerros YT; Nwaru BI; Kankaanranta H; Chabok A; Leppert J; Backman H; Hedman L; Isaksson K; Michaelsson K; Haggstrom C; Stocks T
  • Article: BMJ OPEN. 2024;14(7):e084836
    da Silva M; Fritz J; Mboya IB; Sun M; Wahlstrom J; van Guelpen B; Michalsson K; Magnusson PKE; Melander O; Sandin S; Yin W; Trolle Lagerros Y; Nwaru B; Leppert J; Chabok A; Pedersen NL; Elmstahl S; Isaksson K; Ingvar C; Hedman L; Backman H; Haggstrom C; Stocks T
  • Journal article: EUROPEAN JOURNAL OF EPIDEMIOLOGY. 2024;39(7):785-793
    Liang C; Dobson AJ; Chung H-F; van der Schouw YT; Sandin S; Weiderpass E; Mishra GD
  • Article: DIABETOLOGIA. 2024;67(7):1315-1327
    Metsala J; Risnes K; Persson M; Veijola R; Pulakka A; Heikkila K; Alenius S; Gissler M; Opdahl S; Sandin S; Kajantie E
  • Article: JAMA PSYCHIATRY. 2024;81(7):673-680
    Sandin S; Yip BHK; Yin W; Weiss LA; Dougherty JD; Fass S; Constantino JN; Hailin Z; Turner TN; Marrus N; Gutmann DH; Sanders SJ; Christoffersson B
  • Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2024;33(6):788-795
    Habeshian TS; Peeri NC; De Vivo I; Schouten LJ; Shu X-O; Cote ML; Bertrand KA; Chen Y; Clarke MA; Clendenen TV; Cook LS; Costas L; Dal Maso L; Freudenheim JL; Friedenreich CM; Gallagher G; Gierach GL; Goodman MT; Jordan SJ; La Vecchia C; Lacey JV; Levi F; Liao LM; Lipworth L; Lu L; Matias-Guiu X; Moysich KB; Mutter GL; Na R; Naduparambil J; Negri E; O'Connell K; O'Mara TA; Onieva Hernandez I; Palmer JR; Parazzini F; Patel AV; Penney KL; Prizment AE; Ricceri F; Risch HA; Sacerdote C; Sandin S; Stolzenberg-Solomon RZ; van den Brandt PA; Webb PM; Wentzensen N; Wijayabahu AT; Wilkens LR; Xu W; Yu H; Zeleniuch-Jacquotte A; Zheng W; Du M; Setiawan VW
  • Article: HEPATOLOGY. 2024;79(6):1324-1336
    Huang Y-H; Loftfield E; Argirion I; Adami H-O; Albanes D; Chan AT; Fedirko V; Fraser GE; Freedman ND; Giles GG; Hartge P; Katzke V; Knutsen SF; Lacey J; Liao LM; Luo J; Milne RL; O'Brien KM; Peters U; Poynter JN; Purdue MP; Robien K; Sandin S; Sandler DP; Setiawan VW; Kang JH; Simon TG; Sinha R; Vopham T; Weinstein SJ; White E; Zhang X; Mcglynn KA; Campbell PT; Lee M-H; Koshiol J
  • Article: DIABETIC MEDICINE. 2024;41(6):e15278
    Sandin S; Jarnbert-Pettersson H; Persson M
  • Journal article: JOURNAL OF THE ROYAL SOCIETY OF NEW ZEALAND. 2024;54(3):290-315
    Howden-Chapman P; Crane J; Keall M; Pierse N; Baker MG; Cunningham C; Amore K; Aspinall C; Bennett J; Bierre S; Boulic M; Chapman R; Chisholm E; Davies C; Fougere G; Fraser B; Fyfe C; Grant L; Grimes A; Halley C; Logan-Riley A; Nathan K; Olin C; Ombler J; O'Sullivan K; Pehi T; Penny G; Phipps R; Plagman M; Randal E; Riggs L; Robson B; Ruru J; Shaw C; Schrader B; Teariki MA; Barnard LT; Tiatia R; Toy-Cronin B; Tupara H; Viggers H; Wall T; Wilkie M; Woodward A; Zhang W
  • Article: THORAX. 2024;79(6):508-514
    Liang C; Chung H-F; Dobson A; Sandin S; Weiderpass E; Mishra GD
  • Article: LANCET REGIONAL HEALTH-EUROPE. 2024;40:100902
    Yin W; Pulakka A; Reichenberg A; Kolevzon A; Ludvigsson JF; Risnes K; Lahti-Pulkkinen M; Persson M; Silverman ME; Aden U; Kajantie E; Sandin S
  • Article: GENOME BIOLOGY. 2024;25(1):104
    Pan L; Parini P; Tremmel R; Loscalzo J; Lauschke V; Maron B; Paci P; Ernberg I; Tan NS; Liao Z; Yin W; Rengarajan S; Li X
  • Preprint: MEDRXIV. 2024;MEDRXIV
    Strom NI; Gerring ZF; Galimberti M; Yu D; Halvorsen MW; Abdellaoui A; Rodriguez-Fontenla C; Sealock JM; Bigdeli T; Coleman JR; Mahjani B; Thorp JG; Bey K; Burton CL; Luykx JJ; Zai G; Alemany S; Andre C; Askland KD; Banaj N; Barlassina C; Nissen JB; Bienvenu OJ; Black D; Bloch MH; Boberg J; Børte S; Bosch R; Breen M; Brennan BP; Brentani H; Buxbaum JD; Bybjerg-Grauholm J; Byrne EM; Cabana-Dominguez J; Camarena B; Camarena A; Cappi C; Carracedo A; Casas M; Cavallini MC; Ciullo V; Cook EH; Crosby J; Cullen BA; De Schipper EJ; Delorme R; Djurovic S; Elias JA; Estivill X; Falkenstein MJ; Fundin BT; Garner L; German C; Gironda C; Goes FS; Grados MA; Grove J; Guo W; Haavik J; Hagen K; Harrington K; Havdahl A; Höffler KD; Hounie AG; Hucks D; Hultman C; Janecka M; Jenike E; Karlsson EK; Kelley K; Klawohn J; Krasnow JE; Krebs K; Lange C; Lanzagorta N; Levey D; Lindblad-Toh K; Macciardi F; Maher B; Mathes B; McArthur E; McGregor N; McLaughlin NC; Meier S; Miguel EC; Mulhern M; Nestadt PS; Nurmi EL; O'Connell KS; Osiecki L; Ousdal OT; Palviainen T; Pedersen NL; Piras F; Piras F; Potluri S; Rabionet R; Ramirez A; Rauch S; Reichenberg A; Riddle MA; Ripke S; Rosário MC; Sampaio AS; Schiele MA; Skogholt AH; Sloofman LGSG; Smit J; Soler AM; Thomas LF; Tifft E; Vallada H; van Kirk N; Veenstra-VanderWeele J; Vulink NN; Walker CP; Wang Y; Wendland JR; Winsvold BS; Yao Y; Zhou H; 23andMe Research Team; VA Million Veteran Program, Estonian Biobank; CoGa research team; iPSYCH, HUNT research team; NORDiC research team; Agrawal A; Alonso P; Berberich G; Bucholz KK; Bulik CM; Cath D; Denys D; Eapen V; Edenberg H; Falkai P; Fernandez TV; Fyer AJ; Gaziano JM; Geller DA; Grabe HJ; Greenberg BD; Hanna GL; Hickie IB; Hougaard DM; Kathmann N; Kennedy J; Lai D; Landén M; Le Hellard S; Leboyer M; Lochner C; McCracken JT; Medland SE; Mortensen PB; Neale BM; Nicolini H; Nordentoft M; Pato M; Pato C; Pauls DL; Piacentini J; Pittenger C; Posthuma D; Ramos-Quiroga JA; Rasmussen SA; Richter MA; Rosenberg DR; Ruhrmann S; Samuels JF; Sandin S; Sandor P; Spalletta G; Stein DJ; Stewart SE; Storch EA; Stranger BE; Turiel M; Werge T; Andreassen OA; Børglum AD; Walitza S; Hveem K; Hansen BK; Rück CP; Martin NG; Milani L; Mors O; Reichborn-Kjennerud T; Ribasés M; Kvale G; Mataix-Cols D; Domschke K; Grünblatt E; Wagner M; Zwart J-A; Breen G; Nestadt G; Kaprio J; Arnold PD; Grice DE; Knowles JA; Ask H; Verweij KJ; Davis LK; Smit DJ; Crowley JJ; Scharf JM; Stein MB; Gelernter J; Mathews CA; Derks EM; Mattheisen M
  • Preprint: MEDRXIV. 2024;MEDRXIV
    Strom NI; Halvorsen MW; Tian C; Rück C; Kvale G; Hansen B; Bybjerg-Grauholm J; Grove J; Boberg J; Nissen JB; Damm Als T; Werge T; de Schipper E; Fundin B; Hultman C; Höffler KD; Pedersen N; Sandin S; Bulik C; Landén M; Karlsson E; Hagen K; Lindblad-Toh K; Nordic OCD and Related Disorders Consortium (NORDi; 23andMe Research Team; PGC TS/OCD working group; Hougaard DM; Meier SM; Hellard SL; Mors O; Børglum AD; Haavik J; Hinds DA; Mataix-Cols D; Crowley JJ; Mattheisen M
  • Article: EUROPEAN PSYCHIATRY. 2024;67(1):e11
    Persson M; Tedroff K; Yin W; Franko MA; Sandin S
  • Journal article: ALZHEIMERS & DEMENTIA. 2023;19(S23)
    Levine SZ; Rotstein A; Beeri MS; Weinstein G; Reichenberg A; Sandin S; Kodesh A
  • Journal article: NEW ZEALAND GEOGRAPHER. 2023;79(3):222-233
    Fyfe C; Telfar Barnard L; Howden-Chapman P; Bennett J
  • Article: DIABETES CARE. 2023;46(11):2024-2034
    Chung H-F; Dobson AJ; Hayashi K; Hardy R; Kuh D; Anderson DJ; van der Schouw YT; Greenwood DC; Cade JE; Demakakos P; Brunner EJ; Eastwood SV; Sandin S; Weiderpass E; Mishra GD
  • Article: PSYCHOLOGICAL MEDICINE. 2023;53(15):7300-7308
    Yin W; Norrback M; Levine SZ; Rivera N; Buxbaum JD; Zhu H; Yip B; Reichenberg A; Askling J; Sandin S
  • Show more

Staff and contact

Group leader

All members of the group

Other people connected to the group

  • Zhong, Qiaofeng

Visiting address

̽ѡ, Department of Medical Epidemiology and Biostatistics, Nobels väg 12A, Stockholm, 171 77, Sweden

Postal address

̽ѡ, Department of Medical Epidemiology and Biostatistics, PO Box 281, Stockholm, 171 77, Sweden

PAGES

"PAGES" is an abbreviation for “Population-Based Autism Genetics and Environmental Study”, which illustrates that it is not only a single gene that leads to an increased risk of autism but a complex pattern of several different genes and environmental factors, which in combination creates increased vulnerability. The PAGES study is a collaboration between ̽ѡ and the at the Icahn School of Medicine in New York, USA, one of the world's leading research institutes for autism research. Most of the funding comes from the USA, from national research grants, but also from donations from people who want to help to promote research on autism spectrum states.

What is Autism Spectrum Disorder?

ASD is a disorder that affects at least 1% of all children and adolescents in Sweden. The first signs of ASD are typically seen during early pre-school age and are characterized by communication problems and difficulty to interpret and understand other people's thoughts and feelings.
Both genes and the environment are important causes for ASD. Research from our group using collected genetic material has previously shown that genes are of importance. There are most likely many genes involved in the development of autism and these probably affect the production and absorption of important proteins in the brain cells. An increased sensitivity in these systems may increase the risk of ASD, especially in combination with external stresses and environmental factors. More information about ASD can be found here on the or on the website.

Study information

About 1 in 100 are diagnosed with ASD at some point in life. It has long been assumed that ASD is inherited in the family. In recent years, family studies using knowledge about the genetic relationship between different family members have shown that the variation in risk that can be explained by genetic factors is about 80% (this measure is commonly referred to as "heritability"). Previously collected genetic material (blood and saliva samples) from ̽ѡ has also played an important role. We have also been able to demonstrate the high heredity through genetic data.

The causes of autism spectrum states appear to be genetically complex. A large number of genes, each with only a modest effect individually, when acting together can cause a vulnerability and can, together with environmental factors, trigger the ASD.

In recent years, the techniques for genetic studies of complex diseases have developed rapidly. Through genome-wide association studies (GWAS), several vulnerabilities have been identified for type 1 and 2 diabetes, rheumatism, cardiovascular disease, prostate and breast cancer, for example. This has been of great importance for understanding the mechanisms of these diseases. For ASD, several studies have been conducted with promising results that form the basis for further studies, but the findings of these studies have not been possible to be replicated. To move the research in psychiatric genetics forward and close the gaps in knowledge, large and well-defined studies are needed. Using the large Swedish state-of-the-art registers of the Swedish government National Board of Health and Welfare, we have a unique opportunity to achieve these goals.

Approach

In our study we invite people born in Sweden and who have been diagnosed with ASD at some point during their lives. When we invite people to participate in the study, we only have information that the person has been diagnosed with autism at some point in life. We have no data from ̽ѡ records, current health or any other diagnoses. Information about an autism diagnosis comes from the Patient Register, held by the National Board of Health and Welfare. This is a health register for both somatic and psychiatric diagnoses and contains all psychiatric care facilities in Sweden from 1973 and onwards, and to a varying degree, also includes out-patient care. Only clinical specialists may assign an autism diagnosis that is stored in the Patient Register.

The participants are invited through an information letter followed by a telephone call from one of our research nurses. Since people with autism sometimes can be difficult to reach, we try to work with relatives, close relatives and treatment staff when needed. Individuals with autism may exhibit a varying degree of symptoms. For the most severely affected, we have developed a picture support in addition to the information sent to the invited persons, which explains the examination procedure in a simple way, thus increasing the chance that everyone will be able to decide if they want to participate in the study or not.

If the person decides to participate, we first require a signed consent that the person wishes to participate in the study. The person is then asked to give a saliva sample. Sometimes people may have problems with a dry mouth, but we only ask for a small amount of saliva, about 2 ml. If the participant so wishes, it is possible to give a blood sample instead of a saliva sample. All participants are also asked if we can obtain information about them from other national registries, such as the Medical Birth Register, the National Patient Registry, the Multi-Generation Register and the Prescription Register. The purpose is to enable linkage between genetic data and other characteristics of the participants. Examples of such information are the age of the mother and the father when the person was born. The age of parents has been shown to be of importance for developing ASD in several research studies, and it is therefore important to be able to study whether genetic markers can provide any information to better understand these relationships.

When data collection is complete and all analyzes are complete, comparisons will be made to investigate whether genetic variants appear to be more vulnerable to the development of ASD. The group of people with ASD will be compared with control persons who do not have an ASD diagnosis. Processing of the data will be performed without identifying individual persons.

Significance and purpose

The PAGES study is unique in its kind as it is a national population-based study. This means that we request information from all living in a certain geographical area. Using this approach we can avoid many problems when interpreting research findings that may occur if a smaller group of individuals is included. Our research group has experience of conducting similar studies on Obsessive-Compulsive Disorder (EGOs), Schizophrenia (BROAD study) and bipolar disorder (STANLEY study). Since ASD may share certain genetic causative factors with schizophrenia and other psychotic diseases, the overall results of these studies can provide important information and increased understanding of underlying factors.

What is happening in the study?

In October 2018, we will send out the first study invitations. We will then continue recruitment for at least three years. We will update our website continuously to inform about how the study develops and when we publish research findings that are relevant to the study or that use data that our participants have contributed.

In February 2019, we have published a . In this study where genetic data from PAGES were included, for the first time, 12 common gene variants that increase the risk of autism were discovered.

What's the importance of participating in the study?

Participating in a scientific study does not always directly benefit the person involved but the participation can be of major significance to other people who suffer from the same disability or disease, both in our own generation and in future generations, in Sweden as well as internationally. In particular, the understanding of the causes of these conditions can help prevent both the development of ill health and disease and improve treatment.

Participation in the study is entirely voluntary. The participant may, at any time, suspend his participation and by law (GDPR) request that all collected information be deleted.

What happens to the sample?

Each person participating in the study gives a saliva sample of about 2 ml. The samples are sent to the ̽ѡ Biobank where DNA (legacy) is extracted. A subset of the sample is then sent to a genetic laboratory where genetic analyzes are performed. When data collection is complete and all analyzes are complete, comparisons will be made to investigate whether genetic variants appear to be more vulnerable to the development of ASD. Processing of the data will be performed without identifying individuals. Results will always be reported at group level.

Biobank

The samples will be stored in ̽ѡ biobank. Since 2003, there has been a Swedish law on biobanks, the Biobanks Act (BbL 2002: 297), which means that the participant will get information about and approve that samples are stored in a biobank and what they may be used for. The person who has provided a sample also must decide on how the samples may be used in the future. You are always entitled to change your decision at any time.

Research and Ethics

According to Swedish law (Ethics Examination Act - Law 2003: 460) on ethics testing of human-related research), all research projects must be approved by a research ethics committee that assesses whether the project is important and whether it can be implemented without compromising the integrity of the study participant. This study has received such approval by the Regional Ethics Vetting Board in Stockholm. All personal data and samples are protected.

Saved samples are stored with unique codes so that unauthorized users cannot access them. Personal data is protected under the Data Protection Regulation (GDPR), which applies throughout the EU. You can request in writing to find out what data is registered about yourself. Once a year you are is entitled to order such an excerpt without charge. You also have the right to change information about yourself that is incorrect or incorrectly processed.

Responsible for the data register in the study is ̽ѡ, 171 77 Stockholm, tel. 08-524 800 00. Head of the study is research leader Sven Sandin, tel. 08-524 861 22 and Professor Christina Hultman; both belonging to the Department of Medical Epidemiology and Biostatistics at ̽ѡ Solna.

Study personnel

Profile image

Sven Sandin

Statistician
+46852486122
Profile image

Karin Dellenvall

Research Nurse
+46852487427

Publications

The information and data provided by our study participants have already resulted in a number of scientific papers published in highly ranked international scientific journals. See the list below for some examples. All these studies are available to the general public so anyone can read them, so called open access. Naturally there is no information about individuals reported in the papers, but all information is reported on a group level.


Grove J, Ripke S, Als TD, Mattheisen M, Walters RK, Won H, et al
Nat. Genet. 2019 03;51(3):431-444


Sandin S, Lichtenstein P, Kuja-Halkola R, Hultman C, Larsson H, Reichenberg A
JAMA 2017 09;318(12):1182-1184


Gaugler T, Klei L, Sanders SJ, Bodea CA, Goldberg AP, Lee AB, et al
Nat. Genet. 2014 Aug;46(8):881-5


Sanders SJ, He X, Willsey AJ, Ercan-Sencicek AG, Samocha KE, Cicek AE, et al
Neuron 2015 Sep;87(6):1215-1233


Lim ET, Uddin M, De Rubeis S, Chan Y, Kamumbu AS, Zhang X, et al
Nat. Neurosci. 2017 09;20(9):1217-1224



Mol Autism 2017 ;8():21


De Rubeis S, He X, Goldberg AP, Poultney CS, Samocha K, Cicek AE, et al
Nature 2014 Nov;515(7526):209-15

Common risk variants identified in autism spectrum disorder. Grove J, Ripke S, Als TD, et al. bioRxiv 2017;:224774.

ASD and ADHD have a similar burden of rare protein-truncating variants. Satterstrom FK, Walters RK, Singh T, et al. bioRxiv 2018;:277707.


Anttila V, Bulik-Sullivan B, Finucane HK, Walters RK, Bras J, et al
Science 2018 06;360(6395):

Women's lifestyle and health

Project description

Oral contraceptives, use of hormone replacement therapy, dietary habits and other lifestyle factors affect the risk for cancer, cardiovascular diseases and other chronic diseases in young women. Starting in 1991, a comprehensive questionnaire was mailed to 96,000 Swedish women aged 30-49 years.

Approximately 50,000 completed questionnaires were returned providing detailed information on a wide range of lifestyle factors with a focus on oral contraceptive use, diet, UV light exposure, reproductive factors and familial occurrence of cancer. This study is strictly coordinated with a similar study among 60,000 young women in Norway; apart from the dietary component, the questionnaires are identical and joint analyses are planned. In 2003 a second questionnaire was sent to all women to update information on lifestyle changes as well as to access psychiatric morbidity. Currently analysis is ongoing for several lifestyle factors and cancers of the breast, ovarium, endometrial, colorectal, skin, skin melanoma, lymphomas, as well as cardiovascular outcomes (myocardial infarction, haemorrhagic and ischaemic stroke), psychiatric diseases, sleeping disorders and overall mortality.

Several analyses are being performed on different exposures, such as oral contraceptives, BMI, changes in body size and shape, UV radiation exposure, alcohol consumption, smoking, and risk of different cancer sites and overall mortality. The data management and analysis of the follow-up questionnaire is ongoing.

Project period: 1991-ongoing
Main financing: Swedish Cancer Society, Swedish Research Council, Pharmaceutical companies (for the initiation of the study)

Project leader

Profile image

Sven Sandin

Statistician
+46852486122

Project collaborators

Profile image

Elisabete Weiderpass Vainio

Professor
+46852482510
Profile image

Hans-Olov Adami

Professor Emeritus/Emerita

Partners

  • Department of Medical Epidemiology and Biostatistics - KI: Hans-Olov Adami (co-PI), Marie Löf (nutritionist), Sven Sandin (Statistician), Pouran Almstedt (data base manager)
  • University of Tromsø, Norway: Eiliv Lund, Merethe Kumle, Inger Gram, Merethe Kumle, and Tonje Braaten (Tromsø, Norway)
  • Oslo University, Department of Statistics: Marit Veierod
  • University of Auckland, New Zealand: Prof. Robert Scragg (Head of dept. of Epidemiology) and Alistair Stewart (Senior statistician)
  • University of Birmingham, UK : Prof. Maurice Zeegers
  • University of Queensland, Australia : Prof. Gita Mishra

Collaborators

Marie Löf, professor
, database manager

Publications


Jung S, Spiegelman D, Baglietto L, Bernstein L, Boggs D, van den Brandt P, et al
J. Natl. Cancer Inst. 2013 Feb;105(3):219-36


Mishra G, Anderson D, Schoenaker D, Adami H, Avis N, Brown D, et al
Maturitas 2013 Mar;74(3):235-40


Therman S, Suvisaari J, Hultman CM
Int J Methods Psychiatr Res 2014 Mar;23(1):62-8


Cerhan JR, Moore SC, Jacobs EJ, Kitahara CM, Rosenberg PS, Adami HO, et al
Mayo Clin. Proc. 2014 Mar;89(3):335-45


Kitahara CM, Flint AJ, Berrington de Gonzalez A, Bernstein L, Brotzman M, MacInnis RJ, et al
PLoS Med. 2014 Jul;11(7):e1001673


Veierød MB, Couto E, Lund E, Adami HO, Weiderpass E
Int. J. Cancer 2014 Jul;135(2):413-22


Weiderpass E, Sandin S, Lof M, Oh JK, Inoue M, Shimazu T, et al
Nutr Cancer 2014 ;66(7):1132-43


Teras LR, Kitahara CM, Birmann BM, Hartge PA, Wang SS, Robien K, et al
Br. J. Haematol. 2014 Sep;166(5):667-76


Felix AS, Gaudet MM, La Vecchia C, Nagle CM, Shu XO, Weiderpass E, et al
Int. J. Cancer 2015 Mar;136(5):E410-22


Yang HP, Cook LS, Weiderpass E, Adami HO, Anderson KE, Cai H, et al
Br. J. Cancer 2015 Mar;112(5):925-33


Roswall N, Eriksson U, Sandin S, Löf M, Olsen A, Skeie G, et al
Food Nutr Res 2015 ;59():26336


Roswall N, Li Y, Kyrø C, Sandin S, Löf M, Adami HO, et al
Cancer Epidemiol. Biomarkers Prev. 2015 Apr;24(4):755-7


Gaudet MM, Kitahara CM, Newton CC, Bernstein L, Reynolds P, Weiderpass E, et al
Int J Epidemiol 2015 Apr;44(2):673-81


Li Y, Roswall N, Sandin S, Ström P, Adami HO, Weiderpass E
Cancer Causes Control 2015 Jun;26(6):893-902


Roswall N, Sandin S, Löf M, Skeie G, Olsen A, Adami HO, et al
Eur. J. Epidemiol. 2015 Jun;30(6):509-17


Arem H, Moore SC, Patel A, Hartge P, Berrington de Gonzalez A, Visvanathan K, et al
JAMA Intern Med 2015 Jun;175(6):959-67


Löf M, Sandin S, Yin L, Adami HO, Weiderpass E
Eur. J. Epidemiol. 2015 Sep;30(9):1027-34


Shivappa N, Sandin S, Löf M, Hébert JR, Adami HO, Weiderpass E
Br. J. Cancer 2015 Sep;113(7):1099-103


Roswall N, Sandin S, Scragg R, Löf M, Skeie G, Olsen A, et al
J. Intern. Med. 2015 Nov;278(5):531-41


Oh JK, Sandin S, Ström P, Löf M, Adami HO, Weiderpass E
Int. J. Cancer 2015 Oct;137(8):1979-89


Genkinger JM, Kitahara CM, Bernstein L, Berrington de Gonzalez A, Brotzman M, Elena JW, et al
Ann. Oncol. 2015 Nov;26(11):2257-66


Shin A, Sandin S, Lof M, Margolis KL, Kim K, Couto E, et al
BMC Cancer 2015 Nov;15():881


Li Y, Roswall N, Ström P, Sandin S, Adami HO, Weiderpass E
Br. J. Nutr. 2015 Dec;114(12):2093-102


Kitahara C, McCullough M, Franceschi S, Rinaldi S, Wolk A, Neta G, et al
Thyroid 2016 02;26(2):306-18


Hedelin M, Löf M, Sandin S, Adami H, Weiderpass E
Nutr Cancer 2016 ;68(3):388-95


Jung S, Wang M, Anderson K, Baglietto L, Bergkvist L, Bernstein L, et al
Int J Epidemiol 2016 06;45(3):916-28


Moore S, Lee I, Weiderpass E, Campbell P, Sampson J, Kitahara C, et al
JAMA Intern Med 2016 06;176(6):816-25


Goossens ME, Isa F, Brinkman M, Mak D, Reulen R, Wesselius A, et al
Arch Public Health 2016 ;74():30


Vuong K, Armstrong BK, Weiderpass E, Lund E, Adami HO, Veierod MB, et al
JAMA Dermatol 2016 08;152(8):889-96


Wentzensen N, Poole EM, Trabert B, White E, Arslan AA, Patel AV, et al
J. Clin. Oncol. 2016 08;34(24):2888-98


Mishra GD, Chung HF, Pandeya N, Dobson AJ, Jones L, Avis NE, et al
Maturitas 2016 Oct;92():176-185


Licaj I, Sandin S, Skeie G, Adami HO, Roswall N, Weiderpass E
BMJ Open 2016 11;6(11):e012862


Roswall N, Li Y, Sandin S, Ström P, Adami HO, Weiderpass E
Obesity (Silver Spring) 2017 01;25(1):215-222


El Reda D, Ström P, Sandin S, Oh JK, Adami HO, Löf M, et al
Obesity (Silver Spring) 2017 02;25(2):476-485


Mishra GD, Pandeya N, Dobson AJ, Chung HF, Anderson D, Kuh D, et al
Hum. Reprod. 2017 03;32(3):679-686


Campbell PT, Newton CC, Kitahara CM, Patel AV, Hartge P, Koshiol J, et al
Cancer Epidemiol. Biomarkers Prev. 2017 04;26(4):597-606


Roswall N, Sandin S, Adami HO, Weiderpass E
Int J Epidemiol 2017 04;46(2):e8


Jordan SJ, Na R, Johnatty SE, Wise LA, Adami HO, Brinton LA, et al
Obstet Gynecol 2017 06;129(6):1059-1067


Gaudet MM, Carter BD, Brinton LA, Falk RT, Gram IT, Luo J, et al
Int J Epidemiol 2017 06;46(3):881-893


Pilecka I, Sandin S, Reichenberg A, Scragg RKR, David A, Weiderpass E
Front Psychiatry 2017 ;8():107


Yu D, Takata Y, Smith-Warner SA, Blot W, Sawada N, White E, et al
Cancer Epidemiol. Biomarkers Prev. 2017 07;26(7):1060-1070


Nichols HB, Schoemaker MJ, Wright LB, McGowan C, Brook MN, McClain KM, et al
Cancer Epidemiol. Biomarkers Prev. 2017 09;26(9):1360-1369


Scragg R, Sandin S, Löf M, Adami HO, Weiderpass E
Cancer Causes Control 2017 Sep;28(9):985-996

More about this article:

More about this article: Interview with "TOP ̽ѡ news from around the world in 8 minutes" about Dieting and CV risk

Other links

Documents

Keywords:
Autism Spectrum Disorder Biostatistics Diabetes Mellitus, Type 1 Endocrinology and Diabetes Epidemiology Show all
Content reviewer:
Sven Sandin
Gunilla Sonnebring
09-01-2025